Protagenic Therapeutics Inc. (PTIX): Kapitalizatsiya va daromad nisbati
Protagenic Therapeutics (PTIX) kompaniyasidagi samarali boshqaruv R&D xarajatlari ustidan qat'iy nazoratni ta'minlaydi, bu esa grafikdagi joriy P/S darajasi bilan tasdiqlanadi; ushbu parametrning miqdorini aks ettiradi. Robotlashtirilgan protein tahlili qo'l mehnatini minimallashtirish orqali neyrodegeneratsiya davolash vositalarini qidirishni tezlashtiradi. Ushbu strategiya neyropeptidlarning mustaqil preklinik ishlab chiqilishi va ilmiy institutlar bilan tadqiqot ittifoqlari bilan yanada to'ldirilgan.
Protagenic Therapeutics (PTIX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- birja kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Protagenic Therapeutics|PTIX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati protagenic.com|PTIX - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Protagenic|PTIX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Protagenic Therapeutics|Oraliq qoplash koeffitsiyenti protagenic.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
PTIX - Sof foyda|Prognoz qilingan kelajakdagi foyda Protagenic Therapeutics|PTIX - Narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati protagenic.com|PTIX - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Protagenic|PTIX - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Protagenic Therapeutics|PTIX - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati protagenic.com|PTIX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Protagenic Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:Protagenic Therapeutics Inc., PTIX
Blue-chip aktivlarni saralash uchun investorlar bozor kutganlari va haqiqiy operatsion samaradorlikni bir-biridan ajratishlari kerak. Ushbu ko'rsatkich daromad birligi xarajatini aniqlash uchun bozor kapitalizatsiyasini yillik aylanma bilan bog'laydi, bu esa tashqi qo'llab-quvvatlashsiz preklinik neuropeptid tadqiqotlariga e'tibor qaratgan Protagenic Therapeutics (PTIX) kompaniyasi uchun narxning sotuvlarga nisbati grafigini kelajakdagi kashfiyotlarga bog'langan spekulyativ premiumni baholashning asosiy vositasiga aylantiradi.
Raqobatdosh kompaniyalar
BIIB - Sotuvga nisbatan narx|Narxning daromadga nisbati Neurocrine Biosciences, Inc. NBIX|RGC: Kapitalizatsiya va daromad nisbati|Axsome Therapeutics Inc - P/S multiplikatori|Narx/daromad koeffitsiyenti ACADIA Corp ACAD|XENE: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati vikingtherapeutics.com|Kapitalizatsiyaning daromadga nisbati SUPN|CPRX: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati DNLI (Denali Therapeutics Inc)|Kapitalizatsiyaning sotish hajmiga nisbati HRMY|P/S multiplikatori BHVN (Biohaven Ltd.)|Bozor kapitallashuvining daromadga nisbati AMLX|Trevi Therapeutics, Inc. - P/S multiplikatori|Sotuvga nisbatan narx Praxis Precision Medicines Inc|Anavex Corp (AVXL) - Narxning daromadga nisbati|CeriBell EEG - Bozor kapitallashuvining daromadga nisbati|PRTA (Prothena Biosciences) - P/S multiplikatori|P/S multiplikatori Alector Therapeutics|Narxning daromadga nisbati Annexon (ANNX)|OMER: Narxning sotuvga nisbati|P/S multiplikatori NGNE (Neurogene Corp)|AC Immune Inc (ACIU) - Sotuvga nisbatan narx|VYGR: Kapitalizatsiyaning daromadga nisbati|NMRA - P/S multiplikatori|SCLX (Scilex) - Kapitalizatsiyaning daromadga nisbati|TVGN: Kapitalizatsiyaning sotish hajmiga nisbati|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Cognition Therapeutics Inc. (CGTX) - Narx/daromad koeffitsiyenti|P/S multiplikatori IKT|Kapitalizatsiyaning daromadga nisbati cassavasciences.com SAVA|Narxning daromadga nisbati Assertio ASRT|Narx/daromad koeffitsiyenti Coya Therapeutics Inc (COYA)|VTGN - Narxning daromadga nisbati|Narxning sotuvga nisbati OVID|ABOS (Acumen Pharmaceuticals) - Kapitalizatsiyaning daromadga nisbati|CRVO: Kapitalizatsiyaning sotish hajmiga nisbati|ATHE (Alterity Therapeutics Ltd.) - P/S multiplikatori|Clene Nanomedicine (CLNN) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati PEPG (PepGen Inc.)|Jupiter Neurosciences, Inc. - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati Relmada Therapeutics RLMD|ANVS: Kapitalizatsiya va daromad nisbati|Grace Tx - P/S multiplikatori|Sotuvga nisbatan narx Firefly Neuroscience, Inc.|KLTO (anewmeds.com) - Kapitalizatsiyaning daromadga nisbati|NeuroSense Therapeutics Ltd. (NRSN) - P/S multiplikatori|Narxning daromadga nisbati Reviva Pharmaceuticals|MTVA: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati NeurAxis (NRXS)|HSDT - Sotuvga nisbatan narx|Narxning daromadga nisbati Passage Bio PASG|NEUP (Neuphoria Therapeutics, Inc.) - Narxning sotuvga nisbati|NERV - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ATHA (athira.com)|Addex Therapeutics Ltd (ADXN) - Narxning daromadga nisbati|Sotuvga nisbatan narx Alzamend Neuro (ALZN)|Kapitalizatsiyaning daromadga nisbati CYCN|KTTA (Pasithea) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori CRGT|P/S multiplikatori avenuetx.com (ATXI)|P/S multiplikatori BCLI (BrainStorm Cell Therapeutics)|Narx/daromad multiplikatori Cara Therapeutics Inc.|Chromocell Therapeutics Corporation - P/S multiplikatori|Sotuvga nisbatan narx Eliem Therapeutics|intracellulartherapies.com (ITCI) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati LBPH|MRNS (Marinus Pharmaceuticals, Inc.) - P/S multiplikatori|NKGen Biotech Inc (NKGN) - Narx/daromad koeffitsiyenti|P/S multiplikatori NRBO|Kapitalizatsiyaning daromadga nisbati Sage Therapeutics Inc SAGE|Synaptogenix, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati TRVN|VIGL: Kapitalizatsiyaning daromadga nisbati|anewmeds.com - Kapitalizatsiyaning sotish hajmiga nisbati|CERE: P/S multiplikatori
